<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0023290" disease_type="Disease or Syndrome" abbrv="">Kala-azar</z:e> or <z:e sem="disease" ids="C0023290" disease_type="Disease or Syndrome" abbrv="">visceral leishmaniasis</z:e> is a disseminated <z:e sem="disease" ids="C0033740" disease_type="Disease or Syndrome" abbrv="">protozoal infection</z:e> caused by parasites of the genus Leishmania (Leishmania donovani in India) </plain></SENT>
<SENT sid="1" pm="."><plain>Conventional therapy for <z:e sem="disease" ids="C0023290" disease_type="Disease or Syndrome" abbrv="">visceral leishmaniasis</z:e> continues to be pentavalent <z:chebi fb="24" ids="30304,30513">antimony</z:chebi> (<z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="24" ids="30304,30513">antimony</z:chebi> <z:chebi fb="1" ids="24265">gluconate</z:chebi> [SAG]) </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="1" ids="2682">Amphotericin B</z:chebi> is widely used for SAG-unresponsive cases and sometimes even as a first-line drug, especially in endemic areas </plain></SENT>
<SENT sid="3" pm="."><plain>With the conventional regimen of SAG, cardiac toxicity has been reported in 8% to 17% of cases with 5% to 7% of them having fatal toxicity </plain></SENT>
<SENT sid="4" pm="."><plain>Cardiac toxicity is uncommon with <z:chebi fb="1" ids="2682">amphotericin B</z:chebi> with only few isolated reports </plain></SENT>
<SENT sid="5" pm="."><plain>We report some patients with <z:e sem="disease" ids="C0023290" disease_type="Disease or Syndrome" abbrv="">kala-azar</z:e> in whom coadministration of SAG and <z:chebi fb="1" ids="2682">amphotericin B</z:chebi> led to <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> and <z:hpo ids='HP_0001699'>sudden death</z:hpo> </plain></SENT>
</text></document>